IN2014DN07420A - - Google Patents
Info
- Publication number
- IN2014DN07420A IN2014DN07420A IN7420DEN2014A IN2014DN07420A IN 2014DN07420 A IN2014DN07420 A IN 2014DN07420A IN 7420DEN2014 A IN7420DEN2014 A IN 7420DEN2014A IN 2014DN07420 A IN2014DN07420 A IN 2014DN07420A
- Authority
- IN
- India
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/10—Peptides having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1767—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Dermatology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Marine Sciences & Fisheries (AREA)
- Inorganic Chemistry (AREA)
- Cell Biology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261605528P | 2012-03-01 | 2012-03-01 | |
| PCT/US2013/028727 WO2013131040A1 (en) | 2012-03-01 | 2013-03-01 | Topical gels containing alpha connexin c-terminal (act) peptides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014DN07420A true IN2014DN07420A (en) | 2015-04-24 |
Family
ID=49083360
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN7420DEN2014 IN2014DN07420A (en) | 2012-03-01 | 2014-09-03 |
Country Status (18)
| Country | Link |
|---|---|
| US (5) | US8846605B2 (en) |
| EP (1) | EP2819682B1 (en) |
| JP (1) | JP6185937B2 (en) |
| KR (1) | KR102038948B1 (en) |
| CN (1) | CN104271142B (en) |
| AU (1) | AU2013225716B2 (en) |
| BR (1) | BR112014021653B1 (en) |
| CA (1) | CA2866115C (en) |
| DK (1) | DK2819682T3 (en) |
| HK (1) | HK1205451A1 (en) |
| IL (1) | IL234380B (en) |
| IN (1) | IN2014DN07420A (en) |
| MX (1) | MX351881B (en) |
| NZ (1) | NZ629769A (en) |
| RU (1) | RU2657535C2 (en) |
| SG (1) | SG11201405359YA (en) |
| WO (1) | WO2013131040A1 (en) |
| ZA (1) | ZA201406373B (en) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2463181B (en) | 2007-05-14 | 2013-03-27 | Univ New York State Res Found | Induction of a physiological dispersion response in bacterial cells in a biofilm |
| RU2657535C2 (en) | 2012-03-01 | 2018-06-14 | Ферстстринг Рисерч, Инк. | Topical gels containing alpha connexin c-terminal (act) peptides |
| US11246821B2 (en) * | 2016-08-30 | 2022-02-15 | Rohm And Haas Company | Personal care composition |
| AU2018221221B2 (en) * | 2017-02-16 | 2022-03-24 | Xequel Bio, Inc. | Composition and methods for preventing radiation injury and promoting tissue regeneration |
| US20210137809A1 (en) * | 2017-06-14 | 2021-05-13 | Biosolution Co., Ltd | Cosmetic composition for wrinkle reduction or anti-inflammation, containing substance p |
| US11541105B2 (en) | 2018-06-01 | 2023-01-03 | The Research Foundation For The State University Of New York | Compositions and methods for disrupting biofilm formation and maintenance |
| CN112969451A (en) * | 2018-09-12 | 2021-06-15 | 福斯特斯特林研究公司 | Nanoparticle formulations and methods using alpha connexin C-terminal peptides |
| RU2691647C1 (en) * | 2018-11-29 | 2019-06-17 | Артем Иванович Трофименко | Agent for preventing pathological skin scars formation |
| US11751056B2 (en) * | 2020-08-31 | 2023-09-05 | Oracle International Corporation | Methods, systems, and computer readable media for 5G user equipment (UE) historical mobility tracking and security screening using mobility patterns |
| WO2023212446A1 (en) * | 2022-04-29 | 2023-11-02 | Xequel Bio, Inc. | Compositions and methods for treating complications of viral infections and other respiratory disorders |
| CN117582401B (en) * | 2023-12-07 | 2024-04-26 | 唐宁医药科技(济南)有限公司 | Diabetic foot gel and preparation method thereof |
Family Cites Families (46)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3603444A1 (en) * | 1986-02-05 | 1987-08-06 | Thomae Gmbh Dr K | PHARMACEUTICAL PREPARATIONS FOR STABILIZING INTERFERON ALPHA |
| NZ235556A (en) | 1986-11-05 | 1991-06-25 | Ethicon Inc | Breast milk substitute containing recombinant human egf |
| US5234809A (en) | 1989-03-23 | 1993-08-10 | Akzo N.V. | Process for isolating nucleic acid |
| CA2080538A1 (en) * | 1991-10-21 | 1993-04-22 | Joseph V. Bondi | Lyophilized acidic fibroblast growth factor |
| US5401504B1 (en) * | 1993-12-28 | 1998-04-21 | Univ Mississippi Medical Cente | Use of tumeric in wound healing |
| DE60021700T2 (en) | 1999-01-27 | 2006-06-01 | Becker, David, Dr., Abbots Langley | FORMULATIONS CONTAINING ANTISENSE NUCLEOTIDE SPECIFIC FOR CONNEXINE |
| ES2436624T3 (en) | 1999-05-14 | 2014-01-03 | Arbor Vita Corporation | Peptides or peptide analogs for modulation of the binding of a PDZ protein and a PL protein |
| US7250397B2 (en) | 2000-02-23 | 2007-07-31 | Zealand Pharma A/S | Antiarrhythmic peptides |
| EP1387692A4 (en) | 2000-11-11 | 2004-07-21 | Arbor Vita Corp | Molecular interactions in hematopoietic cells |
| WO2002088370A2 (en) | 2001-04-30 | 2002-11-07 | Protiva Biotherapeutics Inc. | Autogene nucleic acids encoding a secretable rna polymerase |
| US20050053918A1 (en) | 2001-05-16 | 2005-03-10 | Technion Research & Development Foundation Ltd. | Method of identifying peptides capable of binding to MHC molecules, peptides identified thereby and their uses |
| US6867283B2 (en) | 2001-05-16 | 2005-03-15 | Technion Research & Development Foundation Ltd. | Peptides capable of binding to MHC molecules, cells presenting such peptides, and pharmaceutical compositions comprising such peptides and/or cells |
| CN1827766B (en) | 2001-06-28 | 2010-08-25 | 徐荣祥 | In vitro cell cultivation method |
| US6685971B2 (en) | 2001-06-28 | 2004-02-03 | Rongxiang Xu | Method and composition for repairing and promoting regeneration of mucosal tissue in the gastrointestinal tract |
| EP1443951A4 (en) | 2001-08-03 | 2006-05-03 | Arbor Vita Corp | Molecular interactions in cells |
| CA2461542A1 (en) | 2001-10-17 | 2003-04-24 | Tudor Morley Griffith | Gap junctions and endothelial-derived hyperpolarizing factor (edhf) |
| JP2003238441A (en) | 2002-02-08 | 2003-08-27 | 英行 ▲高▼野 | Neovascularization inhibitor |
| AU2003234613A1 (en) | 2002-05-15 | 2003-12-02 | Seul, Kyung, Hwan | Method of modulating angiogenesis |
| IL152573A (en) * | 2002-10-31 | 2009-11-18 | Transpharma Medical Ltd | Transdermal delivery system for anti-emetic medication |
| KR20130008653A (en) | 2003-12-03 | 2013-01-22 | 코다 테라퓨틱스 (엔지) 리미티드 | Antisense compounds targeted to connexins and methods of use thereof |
| CN101151043B (en) * | 2004-12-21 | 2013-09-04 | 南卡罗来纳州医科大学研究发展基金会 | Composition and methods for promoting wound healing and tissue regeneration |
| EP2289535B8 (en) * | 2004-12-21 | 2018-08-08 | MUSC Foundation for Research Development | Compositions and methods for promoting wound healing and tissue regeneration |
| EP2510937A1 (en) | 2005-02-03 | 2012-10-17 | Coda Therapeutics Limited | Anti-connexin compounds and use thereof in combination with transplant or grafting procedures |
| CN101198345A (en) * | 2005-06-17 | 2008-06-11 | 雷金纳克斯生物制药公司 | LKKTET and/or LKKTNT peptide compositions which are lyophilized or in a form capable of being lyophilized |
| MX2007015956A (en) * | 2005-06-17 | 2008-03-06 | Regenerx Biopharmaceuticals | Lkktet and/or lkktnt compositions and methods for treating or preventing tissue deterioration, injury or damage. |
| EP1945307B1 (en) * | 2005-10-11 | 2013-03-27 | DPT Laboratories, LTD. | Surfactant-free dispersions, compositions, and use in topical formulations |
| GB0709513D0 (en) * | 2007-05-17 | 2007-06-27 | Helperby Therapeutics Ltd | Topical formulations |
| JP5960944B2 (en) | 2006-11-15 | 2016-08-02 | コーダ セラピューティクス， インコーポレイテッド | Improved methods and compositions for wound healing |
| DK2101791T3 (en) | 2006-12-11 | 2015-01-05 | Coda Therapeutics Inc | ANTICONNEXIN POLYNUCLEOTIDES AS COMPOSITIONS AGAINST DEGRADED HEALTH |
| US20080299228A1 (en) * | 2007-05-29 | 2008-12-04 | Alan Gerald Harris | Topical compositions comprising a macromolecule and methods of using same |
| EP2166845B1 (en) | 2007-06-21 | 2015-10-21 | Musc Foundation for Research Development | Alpha connexin c-terminal (act) peptides for treating age-related macular degeneration |
| CA2592285C (en) | 2007-06-28 | 2019-10-01 | Musc Foundation For Research Development | Compositions comprising connexin polypeptides and methods for promoting wound healing and tissue regeneration using connexin polypeptides |
| CN102105492A (en) * | 2007-12-11 | 2011-06-22 | 科达治疗公司 | Impaired wound healing compositions and treatments |
| CN102920996A (en) | 2007-12-11 | 2013-02-13 | 科达治疗公司 | Impaired wound healing compositions and treatments |
| EP2237786A2 (en) | 2007-12-21 | 2010-10-13 | Coda Therapeutics, Inc. | Use of inhibitors of connexin43 for treatment of fibrotic conditions |
| WO2009085268A2 (en) | 2007-12-21 | 2009-07-09 | Coda Therapeutics, Inc. | Use of anti-connexin peptides, alone or in combination with anti-connexin polynucleotides, for the treatment of surgical adhesions |
| AU2008343840A1 (en) | 2007-12-21 | 2009-07-09 | Coda Therapeutics, Inc. | Use of anti-connexin polynucleotides, peptides or antibodies for the treatment of orthopedic conditions |
| CA2710388A1 (en) | 2007-12-21 | 2009-07-09 | Coda Therapeutics, Inc. | Use of anti-connexin polynucleotides for the treatment of abnormal or excessive scars |
| EP2237795A2 (en) | 2007-12-21 | 2010-10-13 | Coda Therapeutics, Inc. | Use of anti-connexin polypeptide agent in combination with anti-connexin polynucleotide agent for the treatment of fibrotic conditions |
| EP2234656A2 (en) * | 2007-12-21 | 2010-10-06 | Coda Therapeutics, Inc. | Improved medical devices |
| JP2011507859A (en) | 2007-12-21 | 2011-03-10 | コーダ セラピューティクス， インコーポレイテッド | Use of anti-connexin polynucleotides for the treatment of surgical adhesions |
| EP2252320A2 (en) | 2007-12-21 | 2010-11-24 | Coda Therapeutics, Inc. | Use of anti-connexin polynucleotides and peptides for the treatment of abnormal or excessive scars |
| JP2011507858A (en) | 2007-12-21 | 2011-03-10 | コーダ セラピューティクス， インコーポレイテッド | Use of anti-connexin peptides, alone or in combination with anti-connexin polynucleotides, for the treatment of orthopedic conditions |
| WO2009097077A2 (en) * | 2008-01-07 | 2009-08-06 | Coda Therapeutics, Inc. | Wound healing compositions and treatments |
| AU2009255619A1 (en) | 2008-06-04 | 2009-12-10 | Coda Therapeutics, Inc. | Treatment of pain with gap junction modulation compounds |
| RU2657535C2 (en) | 2012-03-01 | 2018-06-14 | Ферстстринг Рисерч, Инк. | Topical gels containing alpha connexin c-terminal (act) peptides |
-
2013
- 2013-03-01 RU RU2014139668A patent/RU2657535C2/en active
- 2013-03-01 EP EP13755720.3A patent/EP2819682B1/en active Active
- 2013-03-01 WO PCT/US2013/028727 patent/WO2013131040A1/en active Application Filing
- 2013-03-01 NZ NZ629769A patent/NZ629769A/en unknown
- 2013-03-01 JP JP2014560104A patent/JP6185937B2/en active Active
- 2013-03-01 AU AU2013225716A patent/AU2013225716B2/en active Active
- 2013-03-01 CN CN201380023492.XA patent/CN104271142B/en active Active
- 2013-03-01 DK DK13755720.3T patent/DK2819682T3/en active
- 2013-03-01 MX MX2014010501A patent/MX351881B/en active IP Right Grant
- 2013-03-01 SG SG11201405359YA patent/SG11201405359YA/en unknown
- 2013-03-01 KR KR1020147027397A patent/KR102038948B1/en active IP Right Grant
- 2013-03-01 CA CA2866115A patent/CA2866115C/en active Active
- 2013-03-01 BR BR112014021653-3A patent/BR112014021653B1/en active IP Right Grant
- 2013-03-15 US US13/815,723 patent/US8846605B2/en active Active
-
2014
- 2014-07-25 US US14/341,406 patent/US9161984B2/en active Active
- 2014-08-29 ZA ZA2014/06373A patent/ZA201406373B/en unknown
- 2014-08-31 IL IL234380A patent/IL234380B/en active IP Right Grant
- 2014-09-03 IN IN7420DEN2014 patent/IN2014DN07420A/en unknown
-
2015
- 2015-06-19 HK HK15105846.8A patent/HK1205451A1/en unknown
- 2015-09-09 US US14/848,916 patent/US10632173B2/en active Active
-
2020
- 2020-04-27 US US16/859,075 patent/US11524049B2/en active Active
-
2022
- 2022-10-06 US US17/938,624 patent/US20230263857A1/en active Pending